X BODY
About X BODY
X-BODY is a biotechnology company that discovers and develops compounds against targets in oncology and ophthalmology. The company's mission is to apply its innovative capabilities to the discovery of human antibodies against high-value therapeutic targets. X-BODY has entered into a number of alliances with other corporations to generate antibody therapeutic candidates. X-BODY's internal efforts are focused on discovering and developing compounds against biologically relevant targets in oncology and ophthalmology. X-BODY was formed in 2008 by industry veterans Richard Wagner, Brant Binder, and Gordon Binder.
Company Metrics
- Employees: 11-50
- Monthly Visits: None
- Tech Stack: 2 active products
Financial Information
- Estimated Revenue:
- Total Funding: 6802465 USD
- Last Funding: 2662465 USD (Venture - Series Unknown)
- Funding Status: M&A
Technology Stack
X BODY actively uses 2 products in their tech stack.
Market Presence
Industries: Biotechnology, Developer Platform, Therapeutics
Headquarters: Waltham, Massachusetts, United States